SCHEDULE: Zeo Scientifix Shareholder George Shapiro Reports 15.1% Stake

George Shapiro, M.D. has filed an amended Schedule 13G, reporting beneficial ownership of 1,311,271 shares, representing 15.1% of Zeo Scientifix, Inc.'s common stock.

Summary

• George Shapiro, M.D. has filed an amendment to Schedule 13G, indicating a significant ownership stake in Zeo Scientifix, Inc.
• Shapiro beneficially owns 1,311,271 shares of Zeo Scientifix common stock.
• This ownership represents 15.1% of the total outstanding shares.
• The calculation of the percentage is based on 7,837,441 shares outstanding as of June 12, 2026, as reported by the company.
• Shapiro has sole voting power and sole dispositive power over these shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a standard disclosure of significant ownership and does not inherently signal positive or negative performance, but rather a stable or increased commitment from a major shareholder.

Positives

• Significant insider ownership by George Shapiro, M.D., indicating confidence in the company.
• Clear disclosure of ownership percentage (15.1%) provides transparency to the market.

Risks

• Concentration of ownership could potentially lead to less diverse shareholder interests.
• Future selling by a large shareholder could impact stock price.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing, which is a disclosure of beneficial ownership.

Management Comments

• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that significant insider ownership, as reported in Schedule 13G filings, can be a signal of management or key stakeholder conviction in a company's prospects, though it is primarily a disclosure requirement rather than a strategic announcement.

Stakeholder Impact

• Shareholders: Increased transparency regarding a major shareholder's stake, potentially influencing market perception.
• Management: Reinforces the importance of maintaining shareholder value to retain confidence of significant owners.

Next Steps

• Monitor future filings from George Shapiro, M.D. for any changes in ownership.
• Observe Zeo Scientifix, Inc.'s performance and strategic announcements for context regarding this ownership level.

Key Dates

Keywords

Zeo Scientifix, Schedule 13G, Shareholder, Ownership, Beneficial Ownership, Common Stock, SEC Filing, George Shapiro